newsfilter
← Latest News
PR Newswire·

Tetra Bio-Pharma Announces Closing of First Tranche with Cannvalate

OTTAWA, ON, May 17, 2022 /PRNewswire/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP) (OTCQB:TBPMF) (FRA:JAM1), a leader in cannabinoid-derived drug discovery and development, is pleased to announce the closing of the first tranche of the p